# Synergy CHC Corp. (SNYR) — capital_raise [announced]
Source: SEC API (secapi.ai) · situation sit_b29b2d169c8f75685797 · retrieved 2026-08-14T01:28:40.104Z

## Overview
Synergy CHC Corp. is a medicinal chemicals and botanical products company (SIC 2833) incorporated in Nevada and trading on NASDAQ under the ticker SNYR.

Synergy CHC Corp. received a notice of default from ACP Agency, LLC on August 11, 2026, for failure to make an interest payment due on August 3, 2026. The forbearance period under the Forbearance Agreement (dated May 28, 2026) terminated on August 6, 2026, and a forbearance fee of $404,173.06 became due and payable. As of the filing date, approximately $17.6 million in principal borrowings remain outstanding under the Term Loan Credit Agreement (dated May 30, 2025), exclusive of accrued interest, fees, and expenses. ACP has reserved all rights and remedies, including the right to charge post-default interest rates, accelerate the obligations, and exercise other remedies available under the credit agreement and related loan documents.

## Terms
- Counterparty: ACP Agency, LLC · Deal value: $17.6M

## Key dates
- Announced 2026-08-11

## Timeline
- 2026-08-11 · 8-K (0001213900-26-087826): 8-K - Synergy CHC Corp. — *Synergy CHC Corp. is a medicinal chemicals and botanical products company (SIC 2833) incorporated in Nevada and trading on NASDAQ under the ticker SNYR.* Synergy CHC Corp. received a notice of default from ACP Agency, LLC on August 11, 2026, for failure to make an interest payment due on August 3, 2026. The forbearance period under the Forbearance Agreement (dated May 28, 2026) terminated on August 6, 2026, and a forbearance fee of $404,173.06 became due and payable. As of the filing date, approximately $17.6 million in principal borrowings remain outstanding under the Term Loan Credit Agreement (dated May 30, 2025), exclusive of accrued interest, fees, and expenses. ACP has reserved all rights and remedies, including the right to charge post-default interest rates, accelerate the obligations, and exercise other remedies available under the credit agreement and related loan documents.
  https://www.sec.gov/Archives/edgar/data/1562733/0001213900-26-087826.txt

## Citations
- 0001213900-26-087826 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000121390026087826